An intracellular protein that binds amyloid-β peptide and mediates neurotoxicity in Alzheimer's disease

Nature

Volumn 389, Issue 6652, 1997, Pages 689-695

  Yan, Shi Du ^a   Fu, Jin ^a   Soto, Claudio ^b   Chen, Xi ^a   Zhu, Huaijie ^a   Al Mohanna, Futwan ^c   Collison, Kate ^c   Zhu, Aiping ^a   Stern, Eric ^a   Saido, Takaomi ^d   Tohyama, Masaya ^e   Ogawa, Satoshi ^e   Roher, Alex ^f   Stern, David ^a  

^a College of Physicians and Surgeons ^*  (United States)

^b NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

^c KING FAISAL SPECIALIST HOSPITAL AND RESEARCH CENTER   (Saudi Arabia)

^d TOKYO METROPOLITAN INSTITUTE OF MEDICAL SCIENCE   (Japan)

^e OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

^f SUN HEALTH RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; CELL PROTEIN; HYDROXYSTEROID DEHYDROGENASE;

ALZHEIMER DISEASE; ARTICLE; CELL MEMBRANE; CELL STRAIN COS1; CONTROLLED STUDY; GENE OVEREXPRESSION; HELA CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOPRECIPITATION; NEUROBLASTOMA CELL; NEUROTOXICITY; PRIORITY JOURNAL; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION;

3-HYDROXYACYL COA DEHYDROGENASES; ALZHEIMER DISEASE; AMINO ACID SEQUENCE; AMYLOID BETA-PROTEIN; ANIMALS; BRAIN; CARRIER PROTEINS; CLONING, MOLECULAR; COS CELLS; HELA CELLS; HUMANS; HYDROXYSTEROID DEHYDROGENASES; MOLECULAR SEQUENCE DATA; PROTEIN BINDING; RECOMBINANT FUSION PROTEINS; TRANSFECTION;

EID: 0013079948     PISSN: 00280836     EISSN: None     Source Type: Journal    
DOI: 10.1038/39522     Document Type: Article

References (50)

1. Haass, C. & Selkoe, D. Cellular procesisng of β-amyloid precursor protein and the genesis of amyloid β-peptide. Cell 75, 1039-1042 (1993).
2. Yankner, B. et al. Neurotoxicity of a fragment of the amyloid precursor associated with Alzheimer's disease. Science 245, 417-420 (1989).
3. Scheuner, D. et al. Secreted amyloid β-protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease. Nature Med. 2, 864-869 (1996).
4. Roses, A. From genes to mechanisms to therapies: lessons to be learned for neurological disorders. Nature Med. 2, 267-269 (1996).
5. Cai, X., Golde, T. & Younkin, S. Release of excess amyloid β rotein from a mutant amyloid β protein precursor. Science 259, 514-516 (1993).
6. Hensley, K. et al. A model for β-amyloid aggregation and neurotoxicity based on free radical generation by the peptide: relevance to Alzheimer disease. Proc. Natl Acad. Sci. USA 91, 3270-3274 (1994).
7. Yankner, B., Duffy, L. & Kirschner, D. Neurotrophic and neurotoxic effects of amyloid β protein: reversal by tachykinin neuropeptides. Science 250, 279-282 (1990).
8. Benzi, G. & Moretti, A. Are reactive oxygen species involved in Alzheimer's disease? Neurobiol. Aging 16, 661-674 (1995).
9. Cotman, C. & Anderson, A. A potential role for apoptosis in neurodegeneration and Alzheimer's disease. Mol. Neurobiol. 10, 19-45 (1995).
10. Yan, S.-D. et al. RAGE in Alzheimer's disease: a receptor mediating amyloid-β peptide-induced oxidant stress and neurotoxicity, and microglial activation. Nature 382, 685-691 (1996).
11. Paresce, D., Ghosh, R. & Maxfirled, F. Microglial cells internalize aggregates of the Alzheimer's disease amyloid β-protein via a scavenger receptor Neuron 17, 553-565 (1996).
12. El-Khoury, J. et al. Scavenger receptor-mediated adhesion of microglia to β-amyloid fibrils. Nature 382, 685-691 (1996).
13. Wild-Bode, C. et al. Intracellular generation and accumulation of Aβ terminating at amino acid 42. J. Biol. Chem. 272, 16085-16088 (1997).
14. Xia, W. et al. Enhanced production and oligomerization of the 42-residue amyloid β-protein by chinese hamster ovary cells stably expressing mutant presenilins. J. Biol. Chem. 272, 7977-7982 (1997).
15. Xu, H. et al. Generation of Alzheimer β-amyloid protein in the trans-Golgi network in the apparent absence of vesicle formation. Proc. Natl Acad. Sci. USA 94, 3748-3752 (1997).
16. Tiernari, P. et al. Intracellular and secreted Alzheimer β-amyloid species are generated by distinct mechanisms in cultured hippocampal neurons. Proc. Natl Acad. Sci. USA 94, 4125-4130 (1997).
17. Yoshikawa, K., Aizawa, T. & Hayashi, Y. Degeneration in vitro of post-mitotic neurons overexpressing the Alzheimer amyloid protein precursor. Nature 359, 64-67 (1992).
18. Fuller, S. et al. Intracellular produciton of βA4 amyloid of Alzheimer's disease: modulation by phosphoramidon and lack of coupling to the secretion of the amyloid precursor protein. Biochemistry 34, 8091-8098 (1995).
19. Frackowiak, J. et al. Secretion and accumulation of Alzheimer's β-protein by cultured vascular smooth muscle cells from old and young dogs. Brain Res. 676, 225-230 (1995).
20. Fields, S. & Song, O.-K. A novel genetic system ot detect protein-protein interactions. Nature 340, 245-246 (1991).
21. Kozak, M. An analysis of 5′-noncoding sequences from 699 vertebrate messenger RNAs. Nucleic Acids Res. 15, 8125-8131 (1987).
22. Bernstein, F. et al. The Protein Data Bank: a computer-based archival file for macromolecular structures. J. Mol. Biol. 112, 535-542 (1977).
23. Devereux, J., Haeberli, P. & Smithies, O. A comprehensive set of sequence analysis programs for the VAX. Nucleic Acids Res. 12, 387-395 (1984).
24. Ghosh, D. et al. Three-dimensional structure of holo 3α,20β-hydroxysteroid dehydrogenase: a member of a short-chain dehydrogenase family. Proc. Natl Acad. Sci. USA 88, 10064-10068 (1991).
25. Schembri, M., Bayly, R. & Davies, J. Phosphate concentration regulates transcription of acinetobacter polyhydroxyalkanoic acid biosynthetic genes. J. Bacteriol. 177, 4501-4507 (1995).
26. Behl, C., Davis, J., Lesley, R. & Schubert, D. Hydrogen peroxide mediates amyloid β protein toxidty. Cell 77, 817-827 (1994).
27. Busciglio, J. & Yankner, B. Apoptosis and increased generation of reactive oxygen species in Down's syndrome neurons in vitro. Nature 378, 776-779 (1995).
28. Vitek, M. et al. Advanced glycation endproducts contribute to amyloidosis in Alzheimer disease. Proc. Natl. Acad. Sci. USA 91, 4766-4770 (1994).
29. Van, S.-D. et al. Glycated tau protein in Alzheimer disease: a mechanism for induction of oxidant stress. Proc. Natl Acad. Sci. USA 91, 7787-7791 (1994).
30. Ledcsma, M., Bonay, P., Colaco, C. & Avila, J. Analysis of microtubule-associated protein tau glycation in paired helical filaments. J. Biol. Chem. 269, 21614-2169 (1994).
31. Sherrington, R. et al. Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease. Nature 375, 754-760 (1993).
32. Citron, M. et al. Mutation of the β-amyloid precursor protein in familial Alzheimer's disease increases β-protein production. Nature Med. 3, 67-72 (1997).
33. Levy-Lahad, E. et al. A familial Alzheimer's disease locus on chromosome 1. Science 269, 970-972 (1995).
34. Kovacs, D. et al. Alzheimer-associated presenilins 1 and 2: neuronal expression in brain and localization ot intracellular membranes in mammalian cells. Nature Med. 2, 224-229 (1996).
35. Duff, K. et al. Increased amyloid-β42(43) in brains of mice expressing mutant presenilin 1. Nature 383, 710-713 (1996).
36. Borchelt, D. et al. Familial Alzheimer's disease-linked presenilin 1 variants elevate Aβ1-42/1-40 ratio in vitro and in vivo. Neuron 17, 1005-1013 (1996).
37. Scheuner, D. et al. Secreted amyloid β-protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease. Nature Med. 2, 864-869 (1996).
38. Wolozin, B. et al. Participation of presenilin 2 in apoptosis: enhanced basal activity conferred by an Alzheimer mutaiton. Science 274, 1710-1713 (1996).
39. Wong, P. et al. Presenilin 1 required for Notch 1 and DII1 expression in the paraxial mesoderm. Nature 387, 288-292 (1997).
40. Shen, J. et al. Skeletal and CNS defects in presenilin-1-deficient mice. Cell 89, 629-639 (1997).
41. Knauer, M. et al. Intracellular accumulation and resistance to degradation of the Alzheimer amyloid A4/β protein. Proc. Natl Acad. Sci. USA 89, 7437-7441 (1992).
42. 42 are generated intracellularly in cultured human neurons and their secretion increases with maturation. J. Biol. Chem. 271, 8966-8970 (1996).
43. Fuller, S. et al. Intracellular production of βA4 amyloid of Alzheimer's disease: modulation by phosphoramidon and lack of coupling to the secretion of the amyloid precursor protein. Biochem. 34, 8091-8098 (1995).
44. Yang, A., Knauer, M., Burdick, D. & Glabe, C. Intracellular Aβ1-42 aggregates stimulate the accumulation of stable, insoluble amyloidogenic fragments of the amyloid precursor protein in transfected cells. J. Biol. Chem. 270, 14786-14792 (1995).
45. La Feria, F. et al. Neuronal cell death in Alzheimer's disease correlates with apoE uptake and intracellular Aβ stabilization. J. Clin. Invest. 100, 310-320 (1997).
46. Urmoneit, B. et al. Cerebrovascular smooth muscle cells internalize Alzheimer amyloid beta protein via a protein pathway: implications for cerebral amyloid angiopathy. Lab. Invest. 77 157-166 (1997).
47. Matsubara, E., Soto, C., Governale, S., Frangione, B. & Ghiso, J. ApoJ and Alzheimer's amyloid-β solubility. Biochem. J. 316, 671-679 (1996).
48. Kuwabara, K. et al. Purification and characterization of a novel stress protein, ORP150, from cultured rat astrocytes and its expression in ischemic mouse brain. J. Biol. Chem. 271, 5025-5032 (1996).
49. Saido, T. et al. Amino- and carboxyl-terminal heterogeneity of β-amyloid peptides deposited in human brain. Neurosci. Lett. 215, 173-176 (1996).
50. Yan, S.-D, et al. Nonenzymatically glycated tau in Alzheimer's disease induces neuronal oxidant stress resulting in cytokine gene expression and release of amyloid-β peptide. Nature Med. 1, 693-699 (1995).